***
4/19 8:00
Takeda Pharmaceutical Company Limited submitted "
U.S. FDA Approves Subcutaneous Administration of Takeda’s ENTYVIO for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease
"
***
4/18 17:05
Nippon Denkai, Ltd. submitted "
Notice Regarding Recording of Additional Extraordinary Profit (Insurance Receipt)
"
***
4/18 17:00
SAKATA SEED CORPORATION submitted "
Notice Concerning Status of Acquisition of Own Shares and Completion of Acquisition
"
***
4/18 17:00
HASEKO Corporation submitted "
Corporate Governance Report
"
***
4/18 17:00
BASE, Inc. submitted "
Notice Concerning the Issuance of New Shares as Restricted Stock-Based Compensation
"
HOCHIKI CORPORATION [6745] [E01802]